BBH was created on 2011-12-20 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 482.46m in AUM and 26 holdings. BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.
What is the current price of VanEck Biotech ETF (BBH)?
The current price of VanEck Biotech ETF (BBH) is 248.91. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of VanEck Biotech ETF?
The 52-week high of VanEck Biotech ETF is 263.74. Please refer to the page timestamp for the latest data.
What is the 52-week low of VanEck Biotech ETF?
The 52-week low of VanEck Biotech ETF is 179.25. Please refer to the page timestamp for the latest data.
What is the NAV of VanEck Biotech ETF?
The NAV of VanEck Biotech ETF is 246.48 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
Is VanEck Biotech ETF (BBH) a safe investment?
No investment is completely risk-free. The risk level of VanEck Biotech ETF (BBH) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.